Literature DB >> 14614912

Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice.

S Clarke1, A Zimmer, A M Zimmer, R G Hill, I Kitchen.   

Abstract

The role of endogenous opioid peptides and receptors has recently been investigated using knockout mice. Although the affinities of opioid peptides for opioid receptors has been known for many years there is still some uncertainty over which receptor is the endogenous target for each peptide. To address this issue we have studied using quantitative autoradiography the levels of all four opioid receptor subtypes (micro, delta, kappa and opioid receptor-like 1 [ORL1]) in brains sectioned from enkephalin and dynorphin knockouts, as well as from double knockouts. Because receptor up-regulation has been observed when its cognate ligand-peptide is genetically ablated, regional changes in receptor binding in knockout mice may reflect areas where the peptide ligand is tonically active at its receptor or played a role in receptor regulation. In addition, the study aimed to correlate previously observed behaviour in these animals with receptor modulation. Marked region-specific up-regulation of the micro, delta, and kappa opioid receptors but not ORL1 receptors was observed in proenkephalin and prodynorphin knockouts. In proenkephalin knockouts this was most pronounced for the micro- and delta-receptor and in prodynorphin knockouts for the kappa-receptor. Combinatorial double knockouts did not show any changes in addition to those observed in single knockouts. The largest changes were observed in limbic regions and our results suggest that proenkephalin peptides are tonically active at micro and delta-receptors predominantly in these areas. Prodynorphin peptides appear to regulate mostly the kappa-receptor but they are also modulators of micro- and delta-receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614912     DOI: 10.1016/j.neuroscience.2003.07.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.

Authors:  Michael D Hayward; Alexandra Schaich-Borg; John E Pintar; Malcolm J Low
Journal:  Pharmacol Biochem Behav       Date:  2006-12-12       Impact factor: 3.533

2.  Reduced alcohol consumption in mice lacking preprodynorphin.

Authors:  Yuri A Blednov; Danielle Walker; Marni Martinez; R Adron Harris
Journal:  Alcohol       Date:  2006-10       Impact factor: 2.405

Review 3.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 4.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

Review 5.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.

Authors:  Laura J Sim-Selley; Michael P Cassidy; Antonino Sparta; Venetia Zachariou; Eric J Nestler; Dana E Selley
Journal:  Neuropharmacology       Date:  2011-09-03       Impact factor: 5.250

7.  GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding.

Authors:  Ivone Gomes; Dipendra K Aryal; Jonathan H Wardman; Achla Gupta; Khatuna Gagnidze; Ramona M Rodriguiz; Sanjai Kumar; William C Wetsel; John E Pintar; Lloyd D Fricker; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds.

Authors:  Andras Bilkei-Gorzo; Ildiko Racz; Kerstin Michel; Anne Zimmer; Dietrich Klingmüller; Andreas Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2004-06-09       Impact factor: 4.530

9.  The opioid peptides enkephalin and beta-endorphin in alcohol dependence.

Authors:  Ildiko Racz; Britta Schürmann; Anna Karpushova; Martin Reuter; Sven Cichon; Christian Montag; Robert Fürst; Christian Schütz; Petra E Franke; Jana Strohmaier; Thomas F Wienker; Lars Terenius; Urban Osby; Agneta Gunnar; Wolfgang Maier; Andras Bilkei-Gorzó; Markus Nöthen; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2008-06-27       Impact factor: 13.382

10.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.

Authors:  Florence Noble; Nadia Benturquia; Andras Bilkei-Gorzo; Andreas Zimmer; Bernard P Roques
Journal:  Psychopharmacology (Berl)       Date:  2007-10-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.